KEMWELL’S PHARMACEUTICAL BUSINESSES
KEMWELL’S PHARMACEUTICAL BUSINESSES
Industry:
Pharmaceutical
Address:
Bengaluru, Karnataka, India
Country:
India
Status:
Active
Similar Organizations
TAKATAYA
TAKATAYA engages in energy, home appliances, and pharmaceutical businesses.
More informations about "Kemwell’s pharmaceutical businesses"
Recipharm AB: Recipharm creates a global CDMO leader
Apr 18, 2016 Anurag Bagaria, Managing Director of Kemwell commented “I am delighted about the combination of Kemwell’s pharmaceutical business with Recipharm, both of which have …See details»
Recipharm to acquire Kemwell’s CDMO operations in US, Sweden …
Apr 18, 2016 Kemwell’s businesses in Sweden and the US employ nearly 260 people in total. The US development business is involved in the development of inhalation, liquid, semi-solid, …See details»
Swedish firm Recipharm buys Kemwell businesses for …
Apr 19, 2016 Recipharm AB, a Swedish company, active as a pharmaceutical contract development and manufacturing organisation (CDMO), has agreed to acquire Kemwell’s pharmaceutical contract development and manufacturing …See details»
Recipharm AB: Recipharm completes acquisition of ... - Business Wire
May 23, 2016 On 18 April 2016, Recipharm announced that it had entered into two separate agreements to acquire pharmaceutical contract development and manufacturing operations …See details»
Recipharm creates a global CDMO leader through SEK 1.7 billion ...
Apr 18, 2016 The company signs two separate agreements to acquire Kemwell’s pharmaceutical contract development and manufacturing (CDMO) businesses. The first acquisition, …See details»
Recipharm acquires Kemwell’s pharmaceutical businesses in India …
Feb 20, 2017 Sweden's Recipharm has completed the previously announced acquisition of Kemwell’s pharmaceutical businesses in Bengaluru, India, in a deal valued at Skr1.05bn …See details»
Recipharm completes strategic acquisition in India
Recipharm AB announces that it has now concluded the acquisition of Kemwell’s pharmaceutical businesses located in Bengaluru, India. Highlights. Expands position in emerging markets …See details»
Kemwell’s pharmaceutical businesses acquired by Recipharm
Feb 20, 2017 Kemwell’s pharmaceutical businesses acquired by Recipharm . Save . Summary. Overview. ... Kemwell’s pharmaceutical businesses Kemwell’s pharmaceutical businesses. …See details»
CDMO Recipharm Completes Strategic Acquisition in India
Feb 24, 2017 The acquisition price for the businesses in India amounts to INR 7,980 million (SEK 1,058 million 3) on a cash and debt free basis. As part of the transaction Recipharm also …See details»
Recipharm to acquire two CDMO businesses from Kemwell for …
Apr 18, 2016 Recipharm has agreed to buy Kemwell’s pharmaceutical contract development and manufacturing (CDMO) businesses for a total of SEK1.7bn in two separate deals. The first, …See details»
In $205 million deal, Recipharm buys Kemwell’s US, India CDMO …
Apr 21, 2016 Kemwell employed 50 employees at its Research Triangle Park, North Carolina location, 210 in Sweden, and 1,400 in India (for its CDMO business). “These transactions …See details»
Recipharm completes strategic acquisition in India
Feb 20, 2017 The acquisition price for the businesses in India amounts to INR 7 980 million (SEK 1,058m on a cash and debt free basis. As part of the transaction Recipharm also has a …See details»
Top Rated Contract Manufacturer in India | Kemwell Biopharma
Kemwell’s facilities, located in Bangalore, India, are designed with technological support from a leading German biopharma company. ... Sold global Pharma business to Recipharm; Kemwell …See details»
Cipla and Kemwell Biopharma announce execution of a joint …
Aug 25, 2021 Accelerates Cipla’s global lung leadership agenda. Mumbai, India, August 25, 2021: Cipla Limited (BSE: 500087 | NSE: CIPLA EQ, hereafter referred to as “Cipla”), a …See details»
Recipharm Completes Kemwell Acquisition - pharmtech.com
Feb 20, 2017 Recipharm’s addition of Kemwell’s Bengaluru, India facility expands its solid- and liquid-dosage capabilities. News. All News Top News Industry News Bio/Pharma News …See details»
Kemwell - Pharmaceutical Technology
Kemwell is a contract development and manufacturing organisation serving the pharmaceutical industry, offering both small and large module production, development, and global …See details»
Recipharm creates a global CDMO leader through SEK 1.7 billion ...
Of Kemwell’s pharmaceutical business with Recipharm, both of which have many complementary capabilities. I am confident that together we will be even more successful and we look forward …See details»
Cipla and Kemwell Biopharma announce execution of a joint …
Cipla’s respiratory prowess combined with Kemwell’s expertise in biologics will accelerate bringing these essential products to market. Umang Vohra, Managing Director & Global Chief …See details»
Kemwell - Pharmaceutical - Products, Competitors, Financials, …
About Kemwell - Pharmaceutical. Kemwell provides customized product development and manufacturing solutions to pharmaceutical and biopharmaceutical organizations worldwide. …See details»
Business Analyst – Biomedical research (with Product Owner
1 day ago Your responsibilities include but are not limited to Domain Expertise:Apply in-depth knowledge of biomedical research processes, including chemical, pre-clinical, and clinical …See details»